Contributors |
|
xi | |
Preface |
|
xv | |
|
1 Posttranslational Modifications of Proteins and Their Role in Biological Processes and Associated Diseases |
|
|
|
|
|
|
|
|
|
|
1 | (3) |
|
2 Major Posttranslational Modifications |
|
|
4 | (11) |
|
3 Functions of Posttranslational Modifications |
|
|
15 | (4) |
|
4 Diseases Associated With Posttranslational Modifications |
|
|
19 | (2) |
|
5 Role of Posttranslational Modifications in Protein-Protein Interaction |
|
|
21 | (1) |
|
6 Role of PTMs in Replication |
|
|
22 | (3) |
|
7 Role of PTMs in Transcription |
|
|
25 | (2) |
|
8 Role of PTMs in Translation |
|
|
27 | (1) |
|
9 Chemical and Functional Aspects of Protein PTMs |
|
|
28 | (1) |
|
10 Role of PTMs in Histone Modification |
|
|
29 | (2) |
|
11 Conclusion and Future Prospectus |
|
|
31 | (1) |
|
|
32 | (3) |
|
|
35 | (2) |
|
2 Clinical Perspective of Posttranslational Modifications |
|
|
|
|
|
|
|
|
|
37 | (1) |
|
|
38 | (5) |
|
|
43 | (2) |
|
|
45 | (1) |
|
|
46 | (1) |
|
|
47 | (2) |
|
|
49 | (2) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
53 | (5) |
|
11 Conclusion and Future Perspective |
|
|
58 | (1) |
|
|
58 | (11) |
|
3 Phosphorylation and Acetylation of Proteins as Posttranslational Modification: Implications in Human Health and Associated Diseases |
|
|
|
|
|
|
|
|
|
69 | (1) |
|
|
70 | (7) |
|
|
77 | (4) |
|
4 Conclusion and Future Prospects |
|
|
81 | (1) |
|
|
81 | (6) |
|
4 Protein Modifications and Lifestyle Disorders |
|
|
|
|
|
|
87 | (1) |
|
2 Deregulated Adipocyte Proteomc in Obesity |
|
|
88 | (4) |
|
3 Protcostasis in Diabetes |
|
|
92 | (2) |
|
4 Protein Modification in Cardiovascular Diseases |
|
|
94 | (3) |
|
5 Modified Proceome in Rheumatoid Arthritis |
|
|
97 | (4) |
|
6 Conclusion and Future Aspects |
|
|
101 | (8) |
References |
|
102 | (6) |
Further Reading |
|
108 | (253) |
|
5 Ubiquitin Mediated Posttranslational Modification of Proteins Involved in Various Signaling Diseases |
|
|
|
|
|
|
|
109 | (2) |
|
2 Ubiquitinadon in Inflammatory Pathways |
|
|
111 | (1) |
|
3 Implications of UPS in Cancer |
|
|
112 | (6) |
|
4 E3 Ligases in Diabetic Retinopathy (DR) |
|
|
118 | (1) |
|
5 Implications of UPS in Neurodegenerative Diseases |
|
|
119 | (3) |
|
6 Implications of UPS in Renal Disorders |
|
|
122 | (1) |
|
7 Conclusion and Future Perspectives |
|
|
123 | (2) |
|
|
125 | (6) |
|
6 Role of Glycosylation in Modulating Therapeutic Efficiency of Protein Pharmaceuticals |
|
|
|
|
|
|
|
|
|
131 | (1) |
|
2 Challenges Associated With Protein Pharmaceuticals |
|
|
132 | (2) |
|
3 Protein Glycosylation and Its Pharmacological Significance |
|
|
134 | (1) |
|
4 Modulation of Therapeutically Important Properties of Proteins by Glycoengincering |
|
|
135 | (4) |
|
5 Conclusion and Future Direction |
|
|
139 | (1) |
|
|
140 | (5) |
|
7 Posttranslational Modification of Heterologous Human Therapeutics in Plant Host Expression Systems |
|
|
|
|
|
|
|
|
145 | (2) |
|
2 N-Glycosylation as a Major Posttranslational Modification |
|
|
147 | (2) |
|
3 Factors Affecting the Natural Glycosylation of Plant-Farmed Human Pharmaceuticals |
|
|
149 | (3) |
|
4 Plant Cell Culture Versus Whole Plant Cultivation for Biopharmaceutical Production |
|
|
152 | (2) |
|
5 Developing Humanized and Improved Glycoproteins |
|
|
154 | (2) |
|
6 Glycoengincering: Concept of "Biobetters" and "Biosimilars" |
|
|
156 | (1) |
|
|
157 | (1) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
159 | (1) |
|
12 Benefits of Plant Expression System |
|
|
159 | (1) |
|
13 Limitations of Plant Expression System |
|
|
160 | (1) |
|
14 Conclusion and Future Prospects |
|
|
161 | (1) |
|
|
162 | (9) |
|
8 Protein Modification in Plants in Response to Abiotic Stress |
|
|
|
|
|
|
|
|
171 | (1) |
|
2 Abiotic Stress in Plants |
|
|
172 | (2) |
|
3 Types of Abiotic Stress in Plants and the Proteins Involved Therein |
|
|
174 | (10) |
|
4 Protein Modification in Plants in Response to Stress |
|
|
184 | (5) |
|
5 Conclusion and Future Perspective |
|
|
189 | (1) |
|
|
190 | (9) |
|
|
199 | (4) |
|
9 Posttranslational Modifications Associated With Cancer and Their Therapeutic Implications |
|
|
|
|
Laishram Rajendrakumar Singh |
|
|
|
|
203 | (1) |
|
2 Posttranslational Modifications That Regulate the Mdm2-p53 Interaction |
|
|
204 | (2) |
|
3 Modification of Retionblastoma Tumor Suppressor Protein (pRB) and Its Association to Cell Cycle Progression |
|
|
206 | (1) |
|
4 Regulation of NF-κB by Various Posttranslational Modifications |
|
|
207 | (2) |
|
5 Regulation of Gene Expression Via Histone and Histonc Deacetylase Modifications |
|
|
209 | (2) |
|
6 Deregulation of Tyrosine Kinase by Posttranslational Modifications |
|
|
211 | (1) |
|
7 Posttranslational Modifications in Ras/Raf/MEK/ERK in MAPK Pathway |
|
|
212 | (2) |
|
8 Modification of Signal Transducers and Activators of Transcription |
|
|
214 | (1) |
|
9 Phosphorylation of Cyclin-Dependent Kinases and Their Therapeutic Implications |
|
|
215 | (3) |
|
10 Posttranslational Modification in Cadherins |
|
|
218 | (1) |
|
11 Prenylation and G-Protein Coupled Receptors |
|
|
219 | (1) |
|
12 Summary and Future Perspectives |
|
|
220 | (1) |
|
|
221 | (8) |
|
10 Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies |
|
|
|
|
|
|
229 | (1) |
|
|
230 | (7) |
|
|
237 | (7) |
|
|
244 | (2) |
|
|
246 | (7) |
|
|
253 | (9) |
|
|
262 | (1) |
|
|
262 | (1) |
|
|
263 | (18) |
|
11 Protein Covalent Modification by Homocysteine: Consequences and Clinical Implications |
|
|
|
|
|
Laishram Rajendrakumar Singh |
|
|
|
281 | (1) |
|
2 Homocysteine and Protein Homocysteinylation |
|
|
282 | (1) |
|
3 Protein S-Homocysteinylation |
|
|
283 | (2) |
|
4 Protein N-Homocysteinylation |
|
|
285 | (7) |
|
5 Homocystinuria/Hyperhomocysteinemia: Condition Persisting for Protein Modifications |
|
|
292 | (2) |
|
6 Clinical Complications Associated With Elevated Hey |
|
|
294 | (10) |
|
7 Conclusions and Future Prospects |
|
|
304 | (1) |
|
|
304 | (7) |
|
|
311 | (2) |
|
12 Posttranslational Modifications in Algae: Role in Stress Response and Biopharmaceutical Production |
|
|
|
|
|
|
313 | (1) |
|
2 Posttranslational Modifications in Algae With Respect to Stress Response |
|
|
314 | (9) |
|
3 Posttranslational Modification of Therapeutic Proteins in Microalgae |
|
|
323 | (7) |
|
4 Conclusion and Future Prospects |
|
|
330 | (1) |
|
|
331 | (6) |
|
|
337 | (2) |
|
13 Protein Glycosylation: An Important Tool for Diagnosis or Early Detection of Diseases |
|
|
|
|
|
|
|
|
339 | (1) |
|
2 Protein Posttranslational Modifications and Quest for Clinical Biomarkers |
|
|
340 | (1) |
|
3 Protein Glycosylation and Related Disorders |
|
|
341 | (5) |
|
4 Technological Approaches in Analysis of Protein Glycosylation |
|
|
346 | (4) |
|
5 Conclusions and Future Prospectus |
|
|
350 | (1) |
|
|
351 | (7) |
|
|
358 | (3) |
Index |
|
361 | |